Peer-Reviewed Papers in Refereed Journals
1. Ori Braitbard, Janette Bishara-Shieban, Hava Glickstein, Miriam Kott-Gutkowski Umberto Pace, Deborah G. Rund and Wilfred D. Stein .
An ELISA-based procedure for assaying proteins in digests of human lymphocytes and cell lines, using specifically chosen peptides and appropriate antibodies.
Proteome Science 2006, 4:14, 1-11
Impact Factor: 1.73 Cited by 3 Rank: Q2.
2. Ori Braitbard, Hava Glickstein, Janette Bishara-Shieban, Umberto Pace, Wilfred D. Stein .
Competition between bound and free peptides in an ELISA-based procedure that assays peptides derived from protein digests
Proteome Science 2006, 4:12 , 1-12
Impact Factor: 1.73 Cited by 9 Rank: Q2.
3. Uziel Sandler, Orly Devary, Ori Braitbard, Joel Ohana, Gideon Kass, Ariel M. Rubinstein, Zeev Y. Friedman and Yoram Devary
NEROFE™ - A novel human hormone-peptide with anti-cancer activity
Journal of Experimental Therapeutics and Oncology. Volume 8, Number 4, 2010, p. 327-339.
Cited by 1 Rank: Q3
4. Cesar M. Manna, Ori Braitbard, Esther Weiss-Lavi, Jacob Hochman, and Edit Y. Tshuva . Salan-Ti(IV) Complexes are Highly Robust and Highly Active Towards A Range of Sensitive and Drug Resistant Cell Lines
ChemMedChem. 2012 Apr;7(4):703-8.
Impact Factor: 2.968 Cited by 34 Rank: Q1
5. Reytman L, Braitbard O, Tshuva EY. Dalton Trans. 2012 May 7;41(17):5241-7.
Highly cytotoxic vanadium(V) complexes of salan ligands; insights on the role of hydrolysis.
Impact Factor 4.197 Cited by 40 Rank: Q1
6. Wellhöner H, Weiss A, Schulz A, Adermann K, Braitbard O, Bar-Sinai A, Hochman J. Reversing ABCB1-mediated multi-drug resistance from within cells using translocating immune conjugates.
J Drug Target. 2012 Jun;20(5):445-52.
Impact Factor: 2.741 Cited by 6 Rank: Q1
7. Feldman, D., Roniger, M., Bar-Sinai, A., Braitbard, O., Rajchman, D., Natan, c., Love, D. C., Hanover, J. A. and Hochman
The Signal Peptide of Mouse Mammary Tumor Virus-Env: A Phosphoprotein Tumor Modulator, Molecular Cancer Research 2012.1077-1086
Impact Factor: 4.380 Cited by 24 Rank: Q1
8. Sigalit Meker, Katrin Margulis-Goshen, Ester Weiss, Ori Braitbard, Jacob Hochman, Shlomo Magdassi, and Edit Y. Tshuva
Antitumor Activity of Nano-Formulated Phenolato Titanium (IV) Complexes
Chem.Med.Chem. 2014 Mar 26,1294–1298.
Impact Factor: 2.968 Cited by 14 Rank: Q1.
9. Sigalit Meker, Ori Braitbard, Katrin Margulis-Goshen, Shlomo Magdassi, Jacob Hochman, Edit Tshuva
Highly resistant anticancer titanium (IV) complexes and their mechanistic investigation using F-19 NMR
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, Aug 2014,19, S768-S769
IF: 2.968. Rank: Q1.
10. Sigalit Meker , Ori Braitbard ,Katrin Margulis-Goshen , Shlomo Magdassi , Jacob Hochman and Edit Y. Tshuva
Highly Stable Tetra-Phenolato Titanium (IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity Molecules 2015, 20(10), 18526-18538
Impact Factor: 2.416 Cited by 42 Rank: Q1.
Since latest appointment
11. Lilia Reytman, Ori Braitbard, Jacob Hochman, and Edit Y. Tshuva,
Highly Effective and Hydrolytically Stable Vanadium(V) Amino Phenolato Antitumor Agents
Inorg. Chem. 55, 610 (2016)
Impact Factor 4.820 Cited by 35 Rank: Q1.
12. Ori Braitbard, Maayan Roniger, Allan Bar-Sinai, Dana Rajchman, Tamar Gross, Hillel Abramovitch, Marco La Ferla, Sara Francesch, Francesca Lessi, Antonio Giuseppe Naccarato, Chiara M. Mazzanti, Generoso Bevilacqua and Jacob Hochman.
A New Immunization and Treatment Strategy for Mouse Mammary Tumor Virus (MMTV) Associated cancers.
Oncotarget, 2016 Feb 26. doi: 10.18632
Impact Factor: 6.368 Cited by 9 Rank: Q1
impact factors: 3.444 Cited by 20 . Rank: Q2
14. Sigalit Meker, Ori Braitbard, Matthew D. Hall, Jacob Hochman and Edit Y. Tshuva.
Specific Design of Titanium (IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents
impact factors: 5.447 Cited by 35 Rank: Q1
15. James S. Lawson, Chiara Mazzanti, Prospero Civita , Michele Menicagli , Christopher Ngan Noel J. Whitaker, Jacob Hochman, Ori Braitbard, Benafsha Yosufi , Wendy Glenn
Association of mouse mammary tumor virus with human breast cancer: histology, immunohistochemistry and polymerase chain reaction analyses
Frontiers in Oncology, 2018. 8: 141.
Impact Factor: 4.416 Cited by 16 Rank: Q1
16. Nitzan Ganot, Ori Braitbard, Asaad Jammal, Joseph Tam, Jacob Hochman, and Edit Y Tshuva.
In Vivo Anticancer Activity of a Non-Toxic Inert Phenolato Ti Complex: High Efficacy on Solid Tumors Alone and Combined with Pt Drugs
ChemMedChem 2018, 13, 2290.
Impact factor:3.009 Cited by 16 Rank: Q1.
17. Maya Miller, Anna Mellul, Maya Braun, Dana Sherill-Rofe, Emiliano Cohen, Zohar Shpilt, Irene Unterman, Ori Braitbard, Jacob Hochman, Edit Y Tshuva, Yuval Tabach
Genomic analysis of phenolaTi-treated human breast cancer cells: Ti tackles the Endoplasmic Reticulum
iScience , 101262, 2020
Impact factor:5.8, Cited by 4 Rank: Q1.
18. Gilad Nahari, Ori Braitbard, Liraz Larush Jacob Hochman, and Edit Y. Tshuva
ChemMedChem. 2020 Jul 12
Impact factor:3.124, Cited by 7 Rank: Q1
19. Avitan, Iska, Yudit Halperin, Trishna Saha, Naamah Bloch, Dana Atrahimovich, Baruh Polis, Abraham O. Samson, and Ori Braitbard.
Towards a Consensus on Alzheimer’s Disease Comorbidity?
Journal of Clinical Medicine 10, no. 19: 4360. 2021
Impact factor: 4.241, Cited by 6, Rank: Q1
20. Jacob Hochman and Ori Braitbard
Life after Cleavage: The Story of a β-retroviral (MMTV) Signal Peptide - From Murine Lymphoma to Human Breast Cancer
Viruses, Special Issue "Human Betaretrovirus and Related Diseases" Viruses. 2022 Nov 2;14(11):2435.
Impact factor: 5.818 , Cited by 4, Rank: Q1
21. Ori Braitbard, Allan Bar-Sinai 1 & Jacob Hochman.
Maternal Vaccination impairs lymphoma growth and Ocular/CNS metastasis in the offspring.
Front Immunol. 2024 Dec 18;15:1498272. doi: 10.3389/fimmu.2024.1498272. PMID: 39744643;22.
Impact factor: 5.7, Rank: Q1
22. Braitbard Ori, Hochman Jacob. MMTV and breast cancer – from the animal model to potential immunotherapy.
The Oncologist (Under review)